Grants and Contributions:

Back to search

Title:

Evaluate the Efficacy of a Novel Molecule Metabolite against Cancer

Agreement Number:

960828

Agreement Value:

$58,652.00

Agreement Date:

Nov 23, 2020 - Dec 31, 2021

Description:

Ocean Ltd. has successfully isolated and synthesized a novel molecule from seaweed harvested in NL waters that inhibits the growth of cancer cells. The proposed study will validate the efficacy of this molecule's open-ring metabolites and investigate the hypothesis that its open-ring ester hydrolysis form contributes to, or is responsible for, bioactivity by employing in vitro bioassays to confirm the metabolites bioactivity. Oceans Ltd.'s discovery needs to be fully investigated and patent protected in case the biological activity of the parent compound is mediated in whole or in part by the metabolite form. Therefore, more in vitro data is required to ensure the firm's patent is expanded wide enough to cover both eventualities if the data indicates that is necessary.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

St. John's, Newfoundland & Labrador, CA A1C 2H1

Reference Number:

172-2020-2021-Q3-960828

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

103971404

Recipient Type:

For-profit organization

Recipient's Legal Name:

Oceans Limited

Federal Riding Name:

St. John's South--Mount Pearl

Federal Riding Number:

10007

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

541620